We reviewed the recent literature on medicines used to manage inattention, impulsiveness,
and overactivity in children with pervasive developmental disorders (autistic disorder …

Autism spectrum disorders, a group of five conditions with similar behavioral characteristics,
have received increasing research attention in recent years. Treatments have been …

This article reviews the background and rationale for the choice of the atypical antipsychotic
agent risperidone as the first drug to be studied by the RUPP Autism Network. Risperidone …

Conclusion The behavioral and/or psychiatric symptoms in autistic people as described
above have been viewed by many professionals dealing with autistic populations as …

In the care of children with autism spectrum disorders (ASD), medical treatment is typically
considered an adjunct to educational and behavioral interventions. Nonetheless, large …

Background: Awareness of the impact and prevalence of autism spectrum disorders has
significantly increased in recent years. Given the dearth of reliable interventions, there is …

One of the intriguing aspects of autism spectrum disorders is the unclear pathogenesis. In
the absence of any definite evidence of neurochemical abnormalities, there is currently no …

Our understanding and treatment of children with autism have changed dramatically since
Leo Kanner first formally documented the disorder in 1943. With reference to the historical …

Introduction Autism is a developmental disorder of early childhood onset characterized by
significant delays in socialization and communication as well as repetitive patterns of …

Available pharmacotherapies for autism spectrum disorders (ASD) are reviewed based on
clinical and research experience, highlighting some older drugs with emerging evidence …